Ariad Pharmaceuticals - der letzte Thread

204000 auf USD 2,72  

Schöne Entwicklung gen Norden!  

heut wat passiert oder warum geht die so ab ?

 

sind und di auch zurück......denke ich.e shorties kaufen  

 

wirds grün

 

möchtest du das wissen?

 

mich Gott ;-) wissen tue ich garnichts aber mann darf ja wohl mal einen tipp abgeben ;-)

 

es einen richtigen Ausbruch nach oben gibt, nenn ich dich Gott :-)

 

aber SK gestern fast auf Tageshoch! Das stimmt zumindest schon mal positiv. Bin gespannt

 

 

wohl passiert!?! Nachricht von der FDA?

 

DELAFIELD, Wis. (Stockpickr) -- At Stockpickr, we track daily portfolios of stocks that are the biggest percentage gainers and the biggest percentage losers.





>>5 Stocks Under $10 Set to Soar

Stocks that are making large moves like these are favorites among short-term traders because they can jump into these names and try to capture some of that massive volatility. Stocks that are making big-percentage moves either up or down are usually in play because their sector is becoming attractive or they have a major fundamental catalyst such as a recent earnings release. Sometimes stocks making big moves have been hit with an analyst upgrade or an analyst downgrade.






Regardless of the reason behind it, when a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits. If you time your trade correctly, combining technical indicators with fundamental trends, discipline and sound money management, you will be well on your way to investment success.

>>5 Stocks Insiders Love Right Now

With that in mind, let's take a closer look at a several stocks under $10 that are making large moves to the upside today.

Ariad Pharmaceuticals

Ariad Pharmaceuticals (ARIA) is engaged in the discovery and development of breakthrough medicines to treat cancers by regulating cell signaling with small molecules. This stock closed up 8.5% to $2.79 in Thursday's trading session.

Thursday's Range: $2.58-$2.81
52-Week Range: $2.51-$24.59
Thursday's Volume: 9.66 million
Three-Month Average Volume: 11.93 million

From a technical perspective, ARIA spiked sharply higher here and broke out above some near-term overhead resistance at $2.70 with decent upside volume. This move is quickly pushing shares of ARIA within range of triggering a major breakout trade. That trade will hit if ARIA manages to take out Thursday's high of $2.81 to some more near-term overhead resistance at $2.82 with high volume.

Traders should now look for long-biased trades in ARIA as long as it's trending above Thursday's low of $2.58 or above more support at $2.33 and then once it sustains a move or close above those breakout levels with volume that hits near or above 11.93 million shares. If that breakout hits soon, then ARIA will set up to re-fill some of its previous gap down zone from October that started just above $4.
 

 

Das macht heute Kabommmmmmmmmmmmmmmmmmmmmmmmmmm

 

 

"The Agency now plans to conduct a further in-depth review of relevant data on the benefits and risks of Iclusig and will make recommendations..."

Beachten.  

wird halt doch belohnt!

 

Die FDA muss der EMA-Entscheidung, wenn sie dann irgendwann - inkl. recommendations - formuliert ist, nicht folgen!

FDA ist aber wichtig für Ariad...
 

 

 

http://www.streetinsider.com/Corporate+News/...P+Opinion/8917094.html

Aber auch: http://www.finanznachrichten.de/...-and-certain-officers-aria-008.htm

 

http://www.finanznachrichten.de/...tien/ariad-pharmaceuticals-inc.htm

 

Ariad Pharmaceuticals, Inc. : ARIAD Announces Positive Opinion by the European Medicines Agency on the Continued Availability of Iclusig in Patients with Leukaemias

 

 

ARIAD Pharma (ARIA) Iclusig Receives Positive EMA CHMP Opinion

http://www.streetinsider.com/Corporate+News/...P+Opinion/8917094.html

 

wie es weitergeht wenn bei eröffnung mit volumen gehandelt wird ?! Hält sich bis jetzt recht wacker.